Cabazitaxel

Overview

Cabazitaxel increases CYP3A enzyme activities in rat hepatocytes. The mean ex-vivo human plasma protein binding of Cabazitaxel is 91.6%.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Neurological Disease | Microtubule/Tubulin

Product Information

• Catalog No.: B0084-461977
• CAS No.: 183133-96-2
• Molecular Formula: C45H57NO14
• Molecular Weight: 835.93
• Purity: >98%

Source

Original product source